Cytomegalovirus Active Infection in Critically Ill Children
- PMID: 37523581
- DOI: 10.1097/INF.0000000000004027
Cytomegalovirus Active Infection in Critically Ill Children
Abstract
Objective: To describe the epidemiology, clinical characteristics and outcomes of children with cytomegalovirus (CMV) active infection in the pediatric intensive care unit (PICU) and to investigate risk factors for mortality.
Methods: This was a retrospective cohort study of patients who had CMV DNA detected in blood samples and/or tracheal aspirates by polymerase chain reaction (PCR) during stay at 2 PICUs of a university hospital. Suspected cases without etiological confirmation and patients with laboratory-confirmed CMV infection before PICU admission were excluded.
Results: Demographic, clinical and outcome data were collected from medical records. From January 1, 2012, to December 31, 2019, 4748 children were admitted to the PICUs. Thirty-five (0.74%; 95% CI 0.51%-1.02%) had laboratory-confirmed CMV active infection; 71.4% were immunocompromised and 11 (31.4%) died. Patients who died were older than those who survived (median age 65 vs. 5.5 months, respectively; P = 0.048), and they received antiviral therapy for a shorter time (median 12 vs. 23 days, respectively; P = 0.001). The main causa mortis was septic shock (82%) and in most deceased patients (73%) the last CMV PCR before death was positive. PELOD score >6 was a risk factor for death (RR 2.96; 95% CI 1.07-8.21). Viral load in blood had a poor ability for the prediction of death (area under the receiver operating characteristic curve 0.62; 95% CI 0.37-0.84).
Conclusions: The incidence of CMV active infection during PICU stay was 0.74% in an upper-middle income country with a high CMV seroprevalence. PELOD score higher than 6 was a risk factor for death. No association was observed between CMV viral load and mortality.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
References
-
- Zuhair M, Smit GSA, Wallis G, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol. 2019;29:e2034.
-
- de Mello AL, Ferreira EC, Vilas Boas LS, et al. Cytomegalovirus infection in a day-care center in the municipality of São Paulo. Rev Inst Med Trop Sao Paulo. 1996;38:165–169.
-
- Wang YQ, Zhao XY. Human cytomegalovirus primary infection and reactivation: insights from virion-carried molecules. Front Microbiol. 2020;11:1511.
-
- Alyazidi R, Murthy S, Slyker JA, et al. The potential harm of cytomegalovirus infection in immunocompetent critically ill children. Front Pediatr. 2018;6:96.
-
- Lachance P, Chen J, Featherstone R, et al. Association between cytomegalovirus reactivation and clinical outcomes in immunocompetent critically ill patients: a systematic review and meta-analysis. Open Forum Infect Dis. 2017;4:ofx029.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical